North America Artificial Intelligence in Diagnostics Market Size, Share & Trends Analysis Report By Component (Software, Hardware, and Services), By Diagnosis, By Country and Growth Forecast, 2024 - 2031

The North America Artificial Intelligence in Diagnostics Market would witness market growth of 20.7% CAGR during the forecast period (2024-2031).

The US market dominated the North America Artificial Intelligence in Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,902.4 million by 2031. The Canada market is experiencing a CAGR of 23.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 22.2% during (2024 - 2031).

AI-based dermatology applications use deep learning algorithms to analyze skin images to detect skin diseases, including melanoma, eczema, and psoriasis. Mobile apps powered by AI allow users to perform preliminary skin assessments, improving early diagnosis and treatment accessibility. AI enhances eye disease diagnosis by analyzing retinal scans to detect conditions such as diabetic retinopathy, glaucoma, and macular degeneration. AI-driven eye screening tools provide quick and accurate results, improving early detection and intervention.

Additionally, multiple factors are driving the adoption of AI in diagnostics. The rapid development of deep learning, computer vision, and natural language processing (NLP) has significantly improved the accuracy and efficiency of AI-driven diagnostic tools. AI automates image analysis and decision-making processes by addressing the global shortage of skilled radiologists, pathologists, and other diagnostic specialists.

In Canada, the government’s $196.1 billion investment over ten years, including $46.2 billion in new funding for provinces and territories, will significantly enhance healthcare infrastructure, digital health initiatives, and AI-driven diagnostics. This investment will promote early disease detection, predictive analytics, and AI-powered imaging solutions, improving patient outcomes and reducing diagnostic delays. Additionally, the $2.5 billion allocation for Indigenous healthcare will expand AI-based telemedicine and remote diagnostics, ensuring equitable access to advanced healthcare technologies across underserved communities.

Free Valuable Insights: The Artificial Intelligence in Diagnostics Market is Predict to reach USD 5.80 Billion by 2031, at a CAGR of 21.3%

Based on Component, the market is segmented into Software, Hardware, and Services. Based on Diagnosis, the market is segmented into Neurology, Radiology, Chest & Lung, Oncology, Cardiology, Pathology, and Other Diagnosis. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Siemens Healthineers AG (Siemens AG)
• Zebra Technologies Corporation
• GE HealthCare Technologies, Inc.
• F.Hoffmann-La Roche Ltd.
• Microsoft Corporation
• NVIDIA Corporation
• IBM Corporation
• DeepScribe Inc.
• AliveCor, Inc.
• Digital Diagnostics, Inc. (3Derm Systems, Inc.)

North America Artificial Intelligence in Diagnostics Market Report Segmentation

By Component

• Software
• Hardware
• Services

By Diagnosis

• Neurology
• Radiology
• Chest & Lung
• Oncology
• Cardiology
• Pathology
• Other Diagnosis

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence in Diagnostics Market, by Component
1.4.2 North America Artificial Intelligence in Diagnostics Market, by Diagnosis
1.4.3 North America Artificial Intelligence in Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.5 Porter Five Forces Analysis

Chapter 5. North America Artificial Intelligence in Diagnostics Market by Component
5.1 North America Software Market by Country
5.2 North America Hardware Market by Country
5.3 North America Services Market by Country

Chapter 6. North America Artificial Intelligence in Diagnostics Market by Diagnosis
6.1 North America Neurology Market by Country
6.2 North America Radiology Market by Country
6.3 North America Chest & Lung Market by Country
6.4 North America Oncology Market by Country
6.5 North America Cardiology Market by Country
6.6 North America Pathology Market by Country
6.7 North America Other Diagnosis Market by Country

Chapter 7. North America Artificial Intelligence in Diagnostics Market by Country
7.1 US Artificial Intelligence in Diagnostics Market
7.1.1 US Artificial Intelligence in Diagnostics Market by Component
7.1.2 US Artificial Intelligence in Diagnostics Market by Diagnosis
7.2 Canada Artificial Intelligence in Diagnostics Market
7.2.1 Canada Artificial Intelligence in Diagnostics Market by Component
7.2.2 Canada Artificial Intelligence in Diagnostics Market by Diagnosis
7.3 Mexico Artificial Intelligence in Diagnostics Market
7.3.1 Mexico Artificial Intelligence in Diagnostics Market by Component
7.3.2 Mexico Artificial Intelligence in Diagnostics Market by Diagnosis
7.4 Rest of North America Artificial Intelligence in Diagnostics Market
7.4.1 Rest of North America Artificial Intelligence in Diagnostics Market by Component
7.4.2 Rest of North America Artificial Intelligence in Diagnostics Market by Diagnosis

Chapter 8. Company Profiles
8.1 Siemens Healthineers AG (Siemens AG)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Zebra Technologies Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.6 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Microsoft Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 IBM Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 DeepScribe Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 AliveCor, Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Digital Diagnostics, Inc. (3Derm Systems, Inc.)
8.10.1 Company Overview

TABLE 1 North America Artificial Intelligence in Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 North America Artificial Intelligence in Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Artificial Intelligence in Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Artificial Intelligence in Diagnostics Market
TABLE 5 Acquisition and Mergers– Artificial Intelligence in Diagnostics Market
TABLE 6 North America Artificial Intelligence in Diagnostics Market by Component, 2020 - 2023, USD Million
TABLE 7 North America Artificial Intelligence in Diagnostics Market by Component, 2024 - 2031, USD Million
TABLE 8 North America Software Market by Country, 2020 - 2023, USD Million
TABLE 9 North America Software Market by Country, 2024 - 2031, USD Million
TABLE 10 North America Hardware Market by Country, 2020 - 2023, USD Million
TABLE 11 North America Hardware Market by Country, 2024 - 2031, USD Million
TABLE 12 North America Services Market by Country, 2020 - 2023, USD Million
TABLE 13 North America Services Market by Country, 2024 - 2031, USD Million
TABLE 14 North America Artificial Intelligence in Diagnostics Market by Diagnosis, 2020 - 2023, USD Million
TABLE 15 North America Artificial Intelligence in Diagnostics Market by Diagnosis, 2024 - 2031, USD Million
TABLE 16 North America Neurology Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Neurology Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Radiology Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Radiology Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Chest & Lung Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Chest & Lung Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Oncology Market by Country, 2020 - 2023, USD Million
TABLE 23 North America Oncology Market by Country, 2024 - 2031, USD Million
TABLE 24 North America Cardiology Market by Country, 2020 - 2023, USD Million
TABLE 25 North America Cardiology Market by Country, 2024 - 2031, USD Million
TABLE 26 North America Pathology Market by Country, 2020 - 2023, USD Million
TABLE 27 North America Pathology Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Other Diagnosis Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Other Diagnosis Market by Country, 2024 - 2031, USD Million
TABLE 30 North America Artificial Intelligence in Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 31 North America Artificial Intelligence in Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 32 US Artificial Intelligence in Diagnostics Market, 2020 - 2023, USD Million
TABLE 33 US Artificial Intelligence in Diagnostics Market, 2024 - 2031, USD Million
TABLE 34 US Artificial Intelligence in Diagnostics Market by Component, 2020 - 2023, USD Million
TABLE 35 US Artificial Intelligence in Diagnostics Market by Component, 2024 - 2031, USD Million
TABLE 36 US Artificial Intelligence in Diagnostics Market by Diagnosis, 2020 - 2023, USD Million
TABLE 37 US Artificial Intelligence in Diagnostics Market by Diagnosis, 2024 - 2031, USD Million
TABLE 38 Canada Artificial Intelligence in Diagnostics Market, 2020 - 2023, USD Million
TABLE 39 Canada Artificial Intelligence in Diagnostics Market, 2024 - 2031, USD Million
TABLE 40 Canada Artificial Intelligence in Diagnostics Market by Component, 2020 - 2023, USD Million
TABLE 41 Canada Artificial Intelligence in Diagnostics Market by Component, 2024 - 2031, USD Million
TABLE 42 Canada Artificial Intelligence in Diagnostics Market by Diagnosis, 2020 - 2023, USD Million
TABLE 43 Canada Artificial Intelligence in Diagnostics Market by Diagnosis, 2024 - 2031, USD Million
TABLE 44 Mexico Artificial Intelligence in Diagnostics Market, 2020 - 2023, USD Million
TABLE 45 Mexico Artificial Intelligence in Diagnostics Market, 2024 - 2031, USD Million
TABLE 46 Mexico Artificial Intelligence in Diagnostics Market by Component, 2020 - 2023, USD Million
TABLE 47 Mexico Artificial Intelligence in Diagnostics Market by Component, 2024 - 2031, USD Million
TABLE 48 Mexico Artificial Intelligence in Diagnostics Market by Diagnosis, 2020 - 2023, USD Million
TABLE 49 Mexico Artificial Intelligence in Diagnostics Market by Diagnosis, 2024 - 2031, USD Million
TABLE 50 Rest of North America Artificial Intelligence in Diagnostics Market, 2020 - 2023, USD Million
TABLE 51 Rest of North America Artificial Intelligence in Diagnostics Market, 2024 - 2031, USD Million
TABLE 52 Rest of North America Artificial Intelligence in Diagnostics Market by Component, 2020 - 2023, USD Million
TABLE 53 Rest of North America Artificial Intelligence in Diagnostics Market by Component, 2024 - 2031, USD Million
TABLE 54 Rest of North America Artificial Intelligence in Diagnostics Market by Diagnosis, 2020 - 2023, USD Million
TABLE 55 Rest of North America Artificial Intelligence in Diagnostics Market by Diagnosis, 2024 - 2031, USD Million
TABLE 56 Key Information – Siemens Healthineers AG
TABLE 57 Key information – Zebra Technologies Corporation
TABLE 58 Key Information – GE HealthCare Technologies, Inc.
TABLE 59 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 60 Key Information – Microsoft Corporation
TABLE 61 Key Information – NVIDIA Corporation
TABLE 62 Key Information – IBM Corporation
TABLE 63 Key Information – DeepScribe Inc.
TABLE 64 Key Information – AliveCor, Inc.
TABLE 65 Key Information – Digital Diagnostics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Artificial Intelligence in Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Artificial Intelligence in Diagnostics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2023
FIG 6 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 7 Porter’s Five Forces Analysis – Artificial Intelligence in Diagnostics Market
FIG 8 North America Artificial Intelligence in Diagnostics Market share by Component, 2023
FIG 9 North America Artificial Intelligence in Diagnostics Market share by Component, 2031
FIG 10 North America Artificial Intelligence in Diagnostics Market by Component, 2020 - 2031, USD Million
FIG 11 North America Artificial Intelligence in Diagnostics Market share by Diagnosis, 2023
FIG 12 North America Artificial Intelligence in Diagnostics Market share by Diagnosis, 20231
FIG 13 North America Artificial Intelligence in Diagnostics Market by Diagnosis, 2020 - 2031, USD Million
FIG 14 North America Artificial Intelligence in Diagnostics Market share by Country, 2023
FIG 15 North America Artificial Intelligence in Diagnostics Market share by Country, 2031
FIG 16 North America Artificial Intelligence in Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 17 Recent strategies and developments: Siemens Healthineers AG
FIG 18 SWOT Analysis: Siemens Healthineers AG
FIG 19 SWOT Analysis: Zebra Technologies Corporation
FIG 20 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 21 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Recent strategies and developments: Microsoft Corporation
FIG 23 SWOT Analysis: Microsoft Corporation
FIG 24 SWOT Analysis: NVIDIA Corporation
FIG 25 SWOT Analysis: IBM Corporation
FIG 26 SWOT Analysis: AliveCor, Inc.